{"organizations": [], "uuid": "0a46992a54542a410abff6545031db1f9444b98a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180212.html", "section_title": "Archive News &amp; Video for Monday, 12 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dare-bioscience-enters-into-a-lice/brief-dare-bioscience-enters-into-a-license-agreement-with-strategic-science-and-technologies-idUSFWN1Q210L", "country": "US", "domain_rank": 408, "title": "BRIEF-Dare Bioscience Enters Into A License Agreement With Strategic Science And Technologies", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.458, "site_type": "news", "published": "2018-02-12T20:13:00.000+02:00", "replies_count": 0, "uuid": "0a46992a54542a410abff6545031db1f9444b98a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dare-bioscience-enters-into-a-lice/brief-dare-bioscience-enters-into-a-license-agreement-with-strategic-science-and-technologies-idUSFWN1Q210L", "ord_in_thread": 0, "title": "BRIEF-Dare Bioscience Enters Into A License Agreement With Strategic Science And Technologies", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - dare bioscience inc", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 12 (Reuters) - Dare Bioscience Inc:\n* DARE BIOSCIENCE INC - ON FEB 11, 2018, CO ENTERED INTO A LICENSE AGREEMENT WITH STRATEGIC SCIENCE AND TECHNOLOGIES-D & STRATEGIC SCIENCE TECHNOLOGIES\n* DARE BIOSCIENCE INC - AGREEMENT TO LICENSE SST-6007 (5PCT TOPICAL SILDENAFIL CITRATE CREAM), FROM STRATEGIC SCIENCE & TECHNOLOGIES, LLC Source text: ( bit.ly/2H5LWjg ) Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2H5LWjg"], "published": "2018-02-12T20:13:00.000+02:00", "crawled": "2018-02-13T15:40:59.000+02:00", "highlightTitle": ""}